Ask HopeStage to help me review this study
This study may no longer be open, but we can help you understand it and find similar studies.

This study has public registry information. It focuses on PTSD and currently lists study information in the United States.
Important: this study may not currently be recruiting. HopeStage shows this page to help people understand the study information, but you should verify the current status with the official registry and research team.
This study may no longer be open, but we can help you understand it and find similar studies.
This summary needs review. Please check the official study record and contact the research team for details.
The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.
This study may no longer be open, but we can help you understand it and find similar studies.
Taking part may give access to a new approach being evaluated.
It requires regular follow-up, often through questionnaires or interviews.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Based on the public registry summary, this study is trying to understand: This preclinical phase 1 development study in healthy volunteers seeks to identify if low doses of commonly used non-triggering anesthetic agents might have clinical utility for modulating emotional memory processing and to understand the nature of the brain mechanisms of drug. The study team can confirm the exact objective and what it means for you.
This appears to be a medication / drug study involving Dexmedetomidine, Propofol, Ketamine, Nitrous Oxide, Placebo. The listed phase is PHASE1. Ask the study team what that means in practice for safety, monitoring, and criteria.
This study may concern people with ptsd; age range: From 18 Years to 35 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
This study is sponsored by Southern California Institute for Research and Education, which appears to be a research institute. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
The recruitment status is not clearly listed. Check the official registry or contact the study team. The registry lists an estimated enrollment of 293 participants.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me